CARE - Quality Improvement in Cardiovascular Secondary Prevention in Primary Care, Through Delegation of Consultations to the Nurse.
CARE - Quality Development in Cardiovascular Disease in General Practice
1 other identifier
observational
2,193
1 country
66
Brief Summary
Quality Improvement in Primary Care: delegation of check-ups to nurses in general practice
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2008
Typical duration for all trials
66 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2008
CompletedFirst Submitted
Initial submission to the registry
July 10, 2008
CompletedFirst Posted
Study publicly available on registry
July 14, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedJanuary 16, 2012
January 1, 2012
2.7 years
July 10, 2008
January 13, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cholesterol, HDL -cholesterol, LDL-Cholesterol, Blood pressure, Exercise, Waist-circumference, BMI, Smoking status, fasting plasma-glucose, medication taken
As needed, min. baseline and after 6 months
Secondary Outcomes (1)
Number of visits pr. patients, drop-out
Annually
Study Arms (1)
1
Patients in secondary prevention of cardiovascular disease in primary care
Eligibility Criteria
Primary care clinic
You may qualify if:
- Patients in secondary prevention of cardiopathy (ischaemic heart disease, claudication intermittence, thrombotic apoplexy cerebri, diabetes) who are not followed in an outpatient department.
You may not qualify if:
- Patients who suffer from diabetic nephropathy will be excluded
- According to the general practitioners appraisal, patients who suffer from severe co morbidity can be excluded as well.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (66)
Research Site
Albertslund, Denmark
Research Site
Arhus C, Denmark
Research site
Assens, Denmark
Research Site
Billund, Denmark
Research Site
Brabrand, Denmark
Research Site
Elsinore, Denmark
Research Site
Erslev, Denmark
Research Site
Esbjerg, Denmark
Research Site
Faaborg, Denmark
Research Site
Gentofte Municipality, Denmark
Research Site
Give, Denmark
Research Site
Greve, Denmark
Research Site
Hadsund, Denmark
Research Site
Hedehusene, Denmark
Research Site
Hillerød, Denmark
Research Site
Hinnerup, Denmark
Research Site
Hjallerup, Denmark
Research Site
Hjørring, Denmark
Research Site
Hobro, Denmark
Research Site
Holaek, Denmark
Research Site
Holstebro, Denmark
Research Site
Hornsyld, Denmark
Research Site
Horsens, Denmark
Research Site
Hørning, Denmark
Research Site
Karup, Denmark
Research Site
Kbh. O, Denmark
Research Site
Kerteminde, Denmark
Research Site
Kjellerup, Denmark
Research Site
Klarup, Denmark
Research site
Kobenhavn V, Denmark
Research Site
Kolding, Denmark
Research Site
Kolding C, Denmark
Research Site
Kongens Lyngby, Denmark
Research Site
København Ø, Denmark
Research Site
Køge, Denmark
Research Site
Lemvig, Denmark
Research Site
Lystrup, Denmark
Research Site
Maribo, Denmark
Research Site
Nivå, Denmark
Research Site
Næstved, Denmark
Research Site
Odense C, Denmark
Research Site
Pandrup, Denmark
Research Site
Randers, Denmark
Research Site
Ringsted, Denmark
Research Site
Roskilde, Denmark
Research Site
Rungsted Kyst, Denmark
Research Site
Rødding, Denmark
Research Site
Silkeborg, Denmark
Research Site
Skælskør, Denmark
Research Site
Solrød Strand, Denmark
Research Site
Stege, Denmark
Research Site
Struer Municipality, Denmark
Research Site
Svendborg, Denmark
Research Site
Svinninge, Denmark
Research Site
Sønder Felding, Denmark
Research Site
Sønderborg, Denmark
Research Site
Thisted, Denmark
Research Site
Tune, Denmark
Research Site
Vamdrup, Denmark
Research Site
Varde, Denmark
Research Site
Vejen Municipality, Denmark
Research Site
Vejle, Denmark
Research Site
Vestervig, Denmark
Research Site
Viborg, Denmark
Research Site
Viby J, Denmark
Research Site
Vivild, Denmark
MeSH Terms
Conditions
Study Officials
- STUDY CHAIR
Henrik Ommen, MD
Lægerne i Løgumkloster I/S, Denmark
- STUDY CHAIR
Dorte Knudsen
Lægerne Sønderåparken, Denmark
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 10, 2008
First Posted
July 14, 2008
Study Start
April 1, 2008
Primary Completion
December 1, 2010
Study Completion
December 1, 2010
Last Updated
January 16, 2012
Record last verified: 2012-01